Molecure Revenue

Biotechnology Research • Zwirki i Wigury 101, Warsaw, Poland • 51-100 Employees

Molecure revenue & valuation

Annual revenue	$6,331,070
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$20,300,000
Total funding	$12,600,000

Key Contacts at Molecure

Agnieszka Rajczuk-Szczepańska

Hr Director - Member Of The Management Team

Timi Oshodi

Director Of Preclinical Development

Maurycy Zieliński

Director Of Business Development

Monika Czarnecka

Finance Director

Angelika Muchowicz

Head Of Translational Medicine Associate Director

Kamil Lisiecki

Head Of Preclinical Cmc - Assosiate Director

Katarzyna Drzewicka

Senior Scientist/Associate Director

Company overview

Headquarters	Zwirki i Wigury 101, Warsaw, Mazowieckie 02-089, PL
Phone number	+48225526724
Website	molecure.com
NAICS	541714
Keywords	Pharmaceuticals, , Cancer, Immunotherapy, Inflammatory Diseases, Immuno-Oncology, Medicinal Chemistry, Small Molecule Drug Discovery, Small Molecule Immunomodulators, Arginase, Chitinase, Fibrotic Diseases, Respiratory Diseases
Founded	2012
Employees	51-100
Socials

Molecure Email Formats

Molecure uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@molecure.com), used 63.6% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@molecure.com	63.6%
{first initial}.{last name}	j.doe@molecure.com	27.3%
{last name}.{last name}	doe.doe@molecure.com	9.1%

About Molecure

Molecure is a clinical stage biotechnology company, that uses its world leading medicinal chemistry capabilities to discover and develop first in class small molecule drug candidates that directly modulate underexplored protein targets and the function of RNA to treat multiple incurable diseases. Molecure has generated a diverse pipeline of seven distinct programs with the support of leading academic life science institutions globally. Molecure's lead drug candidate is OATD-01, a first-in-class dual chitinase inhibitor for the treatment of fibrotic and inflammatory diseases, including interstitial lung diseases such as sarcoidosis and idiopathic pulmonary fibrosis (IPF). The phase I study was completed in 2022 and the phase II study in sarcoidosis patients started in March 2024. OATD-02 is the first and only dual acting, highly potent arginase inhibitor in cancer development, involved in both tumor immunity and metabolism. In March 2023, Phase 1 clinical trial was initiated. Molecure’s headquarters and laboratories are located in Warsaw, Poland with an additional laboratories in Łódź. The company is listed on the Warsaw Stock Exchange (ticker: MOC).

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Molecure has 27 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore Molecure's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-08-18	23	$12,600,000

Funding Insights

$12,600,000

Total funding amount

$12,600,000

Most recent funding amount

Number of funding rounds

Molecure Tech Stack

Discover the technologies and tools that power Molecure's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

jQuery UI

JavaScript libraries

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

YouTube

Video players

Bootstrap

UI frameworks

WPML

Translation

WooCommerce

Ecommerce

Frequently asked questions

Molecure is located in Zwirki i Wigury 101, Warsaw, PL.

You can reach Molecure at +48225526724.

Molecure generates an estimated annual revenue of $6,331,070. This revenue figure reflects the company's market position and business performance in its industry.

Molecure has an estimated valuation of $20,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Molecure was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

Molecure has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Molecure has raised a total of $12,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.